Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ALS
CRO
QurAlis, Unlearn link to use machine learning in ALS research
QurAlis hass inked a deal with Unlearn to leverage its AI digital technology for clinical trials focused on amyotrophic lateral sclerosis.
Joseph Keenan
Jun 28, 2023 11:30am
Synchron's brain-computer interface hits one-year safety mark
Mar 31, 2022 10:40am
Orphazyme on last legs amid restructuring, more layoffs
Mar 10, 2022 6:24pm
Maze snares $190M as its top asset aims for clinic
Jan 10, 2022 7:30am
After FDA U-turn, Amylyx heads for IPO to support ALS drug
Dec 17, 2021 10:45am
ALS organizations call on Senate to pass $500M neuro R&D bill
Dec 9, 2021 4:00pm
